Tiansheng Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 6/6
Tiansheng Pharmaceutical Group has a total shareholder equity of CN¥2.1B and total debt of CN¥392.5M, which brings its debt-to-equity ratio to 19.1%. Its total assets and total liabilities are CN¥2.8B and CN¥715.7M respectively.
Key information
19.1%
Debt to equity ratio
CN¥392.50m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥243.03m |
| Equity | CN¥2.06b |
| Total liabilities | CN¥715.75m |
| Total assets | CN¥2.78b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 002872's short term assets (CN¥697.2M) exceed its short term liabilities (CN¥418.0M).
Long Term Liabilities: 002872's short term assets (CN¥697.2M) exceed its long term liabilities (CN¥297.7M).
Debt to Equity History and Analysis
Debt Level: 002872's net debt to equity ratio (7.3%) is considered satisfactory.
Reducing Debt: 002872's debt to equity ratio has reduced from 21.3% to 19.1% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 002872 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 002872 has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 23.6% each year